On the public citation graph

A Refined Model of the HCV NS5A Protein Bound to Daclatasvir Explains Drug-Resistant Mutations and Activity against Divergent Genotypes

0 signed · 96 inferred · view as graph

Inferred edges come from two machine sources: sweeps of open repository metadata (mostly SSRN and Zenodo), and a bulk OpenAlex citation snapshot. Every row below is labelled with the one it came from. Neither is a complete citation index — absence here is not evidence of absence.

Is this your work? Sign in with ORCID and put your name on the claims that are yours.

Claim with ORCID

Reference health. See whether every reference in this work resolves to a known work and none has been retracted — and get a dated CiteStamped badge you can embed.

See reference health

What this work says

Outgoing claims: the papers this work cites, builds on, or argues with.

inferredcites →https://doi.org/10.1002/(sici)1097-0282(199603)38:3<305::aid-bip4>3.0.co;2-yopenalex-snapshot

Reduced surface: An efficient way to compute molecular surfaces

inferredcites →https://doi.org/10.1002/hep.24594openalex-snapshot

Genotypic and phenotypic analysis of variants resistant to hepatitis C virus nonstructural protein 5A replication complex inhibitor BMS-790052 in Humans: In Vitro and In Vivo Correlations

inferredcites →https://doi.org/10.1002/hep.510280433openalex-snapshot

Mutations in the interferon-sensitivity determining region of hepatitis C virus and transcriptional activity of the nonstructural region 5A protein

inferredcites →https://doi.org/10.1002/jcc.20035openalex-snapshot

Development and testing of a general amber force field

inferredcites →https://doi.org/10.1002/jcc.21366openalex-snapshot

How to obtain statistically converged MM/GBSA results

inferredcites →https://doi.org/10.1002/jmr.2266openalex-snapshot

Latest developments in molecular docking: 2010–2011 in review

inferredcites →https://doi.org/10.1002/prot.10028openalex-snapshot

Automated docking to multiple target structures: Incorporation of protein mobility and structural water heterogeneity in AutoDock

inferredcites →https://doi.org/10.1002/prot.21123openalex-snapshot

Comparison of multiple Amber force fields and development of improved protein backbone parameters

inferredcites →https://doi.org/10.1006/jcph.1999.6201openalex-snapshot

NAMD2: Greater Scalability for Parallel Molecular Dynamics

inferredcites →https://doi.org/10.1016/j.bmcl.2012.05.039openalex-snapshot

Synthesis and evaluation of novel potent HCV NS5A inhibitors

inferredcites →https://doi.org/10.1016/j.bmcl.2013.02.023openalex-snapshot

Synthesis and evaluation of non-dimeric HCV NS5A inhibitors

inferredcites →https://doi.org/10.1016/j.bmcl.2013.04.009openalex-snapshot

Discovery of pyrido[2,3-d]pyrimidine-based inhibitors of HCV NS5A

inferredcites →https://doi.org/10.1016/j.cbi.2013.12.001openalex-snapshot

QSAR, docking, dynamic simulation and quantum mechanics studies to explore the recognition properties of cholinesterase binding sites

inferredcites →https://doi.org/10.1016/j.chembiol.2010.05.019openalex-snapshot

Discovery and Characterization of the Laulimalide-Microtubule Binding Mode by Mass Shift Perturbation Mapping

inferredcites →https://doi.org/10.1016/j.compbiolchem.2013.10.006openalex-snapshot

Computational simulation of ligand docking to L-type pyruvate kinase subunit

inferredcites →https://doi.org/10.1016/j.coviro.2013.06.014openalex-snapshot

Antiviral activity and resistance of HCV NS5A replication complex inhibitors

inferredcites →https://doi.org/10.1016/j.jhep.2013.03.030openalex-snapshot

NS5A inhibitors in the treatment of hepatitis C

inferredcites →https://doi.org/10.1016/j.jmgm.2009.12.003openalex-snapshot

Ensemble-based virtual screening reveals dual-inhibitors for the p53–MDM2/MDMX interactions

inferredcites →https://doi.org/10.1016/j.jmgm.2010.12.003openalex-snapshot

Relaxed complex scheme suggests novel inhibitors for the lyase activity of DNA polymerase beta

inferredcites →https://doi.org/10.1016/j.saa.2013.08.013openalex-snapshot

Exploring the site-selective binding of jatrorrhizine to human serum albumin: Spectroscopic and molecular modeling approaches

inferredcites →https://doi.org/10.1016/j.steroids.2013.11.017openalex-snapshot

Structural insights into Estrogen Related Receptor-β modulation: 4-Methylenesterols from Theonella swinhoei sponge as the first example of marine natural antagonists

inferredcites →https://doi.org/10.1016/j.virusres.2012.09.007openalex-snapshot

Small molecule inhibitors of the hepatitis C virus-encoded NS5A protein

inferredcites →https://doi.org/10.1021/ar000033jopenalex-snapshot

Calculating Structures and Free Energies of Complex Molecules: Combining Molecular Mechanics and Continuum Models

inferredcites →https://doi.org/10.1021/ci4003969openalex-snapshot

Detailed Computational Study of the Active Site of the Hepatitis C Viral RNA Polymerase to Aid Novel Drug Design

inferredcites →https://doi.org/10.1021/ct700119mopenalex-snapshot

Clustering Molecular Dynamics Trajectories: 1. Characterizing the Performance of Different Clustering Algorithms

inferredcites →https://doi.org/10.1021/jp3059992openalex-snapshot

LIPID11: A Modular Framework for Lipid Simulations Using Amber

inferredcites →https://doi.org/10.1021/mp4003893openalex-snapshot

A Computational Model for Overcoming Drug Resistance Using Selective Dual-Inhibitors for Aurora Kinase A and Its T217D Variant

inferredcites →https://doi.org/10.1038/ajg.2013.205openalex-snapshot

A Translational Study of Resistance Emergence Using Sequential Direct-Acting Antiviral Agents for Hepatitis C Using Ultra-Deep Sequencing

inferredcites →https://doi.org/10.1038/nature03580openalex-snapshot

Structure of the zinc-binding domain of an essential component of the hepatitis C virus replicase

inferredcites →https://doi.org/10.1038/nature08960openalex-snapshot

Chemical genetics strategy identifies an HCV NS5A inhibitor with a potent clinical effect

inferredcites →https://doi.org/10.1039/9781849737814openalex-snapshot

Successful Strategies for the Discovery of Antiviral Drugs

inferredcites →https://doi.org/10.1053/jhep.2002.30531openalex-snapshot

New therapeutic strategies for hepatitis C

inferredcites →https://doi.org/10.1056/nejmoa1012912openalex-snapshot

Telaprevir for Previously Untreated Chronic Hepatitis C Virus Infection

inferredcites →https://doi.org/10.1073/pnas.1203110110openalex-snapshot

Modeling shows that the NS5A inhibitor daclatasvir has two modes of action and yields a shorter estimate of the hepatitis C virus half-life

inferredcites →https://doi.org/10.1074/jbc.m404761200openalex-snapshot

Structure and Function of the Membrane Anchor Domain of Hepatitis C Virus Nonstructural Protein 5A

inferredcites →https://doi.org/10.1093/nar/gkm276openalex-snapshot

PDB2PQR: expanding and upgrading automated preparation of biomolecular structures for molecular simulations

inferredcites →https://doi.org/10.1109/tpami.1979.4766909openalex-snapshot

A Cluster Separation Measure

inferredcites →https://doi.org/10.1111/j.1747-0285.2012.01340.xopenalex-snapshot

Discovery of Small Molecule Inhibitors that Interact with γ‐Tubulin

inferredcites →https://doi.org/10.1124/mol.112.082347openalex-snapshot

Small Molecule Inhibitors of ERCC1-XPF Protein-Protein Interaction Synergize Alkylating Agents in Cancer Cells

inferredcites →https://doi.org/10.1128/aac.00556-10openalex-snapshot

Resistance Analysis of the Hepatitis C Virus NS5A Inhibitor BMS-790052 in an In Vitro Replicon System

inferredcites →https://doi.org/10.1128/aac.02193-12openalex-snapshot

Characterization of Hepatitis C Virus Resistance from a Multiple-Dose Clinical Trial of the Novel NS5A Inhibitor GS-5885

inferredcites →https://doi.org/10.1128/jvi.00215-11openalex-snapshot

Small Molecules Targeting Hepatitis C Virus-Encoded NS5A Cause Subcellular Redistribution of Their Target: Insights into Compound Modes of Action

inferredcites →https://doi.org/10.1128/jvi.00253-11openalex-snapshot

Distinct Functions of NS5A in Hepatitis C Virus RNA Replication Uncovered by Studies with the NS5A Inhibitor BMS-790052

inferredcites →https://doi.org/10.1128/jvi.02352-08openalex-snapshot

Crystal Structure of a Novel Dimeric Form of NS5A Domain I Protein from Hepatitis C Virus

inferredcites →https://doi.org/10.1371/journal.pone.0027651openalex-snapshot

Effects of Temperature on the p53-DNA Binding Interactions and Their Dynamical Behavior: Comparing the Wild Type to the R248Q Mutant

inferredcites →https://doi.org/10.1371/journal.pone.0051329openalex-snapshot

Virtual Screening and Biological Evaluation of Inhibitors Targeting the XPA-ERCC1 Interaction

inferredcites →https://doi.org/10.2174/157489108784746597openalex-snapshot

NS5A - From Obscurity to New Target for HCV Therapy

inferredcites →https://doi.org/10.4018/978-1-60960-491-2openalex-snapshot

Handbook of Research on Computational and Systems Biology: Interdisciplinary Applications

What points at this work

Incoming claims: where this work appears in other papers’ reference lists and arguments.

inferred← citeshttps://doi.org/10.2139/ssrn.4758294openalex-extracted

Combining Machine Learning, Molecular Dynamics, and Free Energy Analysis for (5ht)-2a Receptor Modulator Classification

inferred← citeshttps://doi.org/10.1002/ardp.201800017openalex-snapshot

Expanding the chemical space of anti‐HCV NS5A inhibitors by stereochemical exchange and peptidomimetic approaches

inferred← citeshttps://doi.org/10.1002/jcb.28581openalex-snapshot

Review on chemogenomic approaches towards hepatitis C viral targets

inferred← citeshttps://doi.org/10.1002/jmv.25357openalex-snapshot

Perspectives towards antiviral drug discovery against Ebola virus

inferred← citeshttps://doi.org/10.1002/med.21554openalex-snapshot

Evolution of efficacious pangenotypic hepatitis C virus therapies

inferred← citeshttps://doi.org/10.1002/wcms.1306openalex-snapshot

Molecular ‘time‐machines’ to unravel key biological events for drug design

inferred← citeshttps://doi.org/10.1007/7355_2018_47openalex-snapshot

The Discovery and Development of Daclatasvir: An Inhibitor of the Hepatitis C Virus NS5A Replication Complex

inferred← citeshttps://doi.org/10.1007/978-4-431-56098-2_1openalex-snapshot

Towards the Control of Hepatitis C

inferred← citeshttps://doi.org/10.1007/s00894-022-05420-4openalex-snapshot

Studies of the symmetric binding mode of daclatasvir and analogs using a new homology model of HCV NS5A GT-4a

inferred← citeshttps://doi.org/10.1007/s10337-016-3157-2openalex-snapshot

Development and Validation of the Chiral HPLC Method for Daclatasvir in Gradient Elution Mode on Amylose-Based Immobilized Chiral Stationary Phase

inferred← citeshttps://doi.org/10.1016/b978-0-12-409547-2.12406-0openalex-snapshot

Direct-Acting Antiviral Agents for the Treatment of Hepatitis C Virus Infection

inferred← citeshttps://doi.org/10.1016/j.bioorg.2020.104089openalex-snapshot

Symmetric benzidine derivatives as anti-HCV agents: Insight into the nature, stereochemistry of the capping amino acid and the size of the terminal capping carbamates

inferred← citeshttps://doi.org/10.1016/j.chroma.2020.461448openalex-snapshot

Unusual complexation behavior between daclatasvir and γ-Cyclodextrin. A multiplatform study

inferred← citeshttps://doi.org/10.1016/j.csbj.2022.06.060openalex-snapshot

Targeting non-structural proteins of Hepatitis C virus for predicting repurposed drugs using QSAR and machine learning approaches

inferred← citeshttps://doi.org/10.1016/j.drudis.2016.11.001openalex-snapshot

Molecular dynamics-driven drug discovery: leaping forward with confidence

inferred← citeshttps://doi.org/10.1016/j.jhep.2016.07.026openalex-snapshot

Future landscape of hepatitis C research – Basic, translational and clinical perspectives

inferred← citeshttps://doi.org/10.1016/j.jmgm.2015.01.015openalex-snapshot

Human PD-1 binds differently to its human ligands: A comprehensive modeling study

inferred← citeshttps://doi.org/10.1016/j.jmgm.2015.09.010openalex-snapshot

Entropy in bimolecular simulations: A comprehensive review of atomic fluctuations-based methods

inferred← citeshttps://doi.org/10.1016/j.jmgm.2016.02.010openalex-snapshot

New design of nucleotide excision repair (NER) inhibitors for combination cancer therapy

inferred← citeshttps://doi.org/10.1016/j.jmgm.2024.108842openalex-snapshot

Combining machine learning, molecular dynamics, and free energy analysis for (5HT)-2A receptor modulator classification

inferred← citeshttps://doi.org/10.1016/j.toxlet.2014.08.007openalex-snapshot

A human ether-á-go-go-related (hERG) ion channel atomistic model generated by long supercomputer molecular dynamics simulations and its use in predicting drug cardiotoxicity

inferred← citeshttps://doi.org/10.1016/j.virol.2014.12.018openalex-snapshot

Daclatasvir inhibits hepatitis C virus NS5A motility and hyper-accumulation of phosphoinositides

inferred← citeshttps://doi.org/10.1021/acs.jmedchem.6b01234openalex-snapshot

Discovery of Chromane Containing Hepatitis C Virus (HCV) NS5A Inhibitors with Improved Potency against Resistance-Associated Variants

inferred← citeshttps://doi.org/10.1021/acsinfecdis.6b00113openalex-snapshot

A Comprehensive Computational Analysis for the Binding Modes of Hepatitis C Virus NS5A Inhibitors: The Question of Symmetry

inferred← citeshttps://doi.org/10.1021/jm501291copenalex-snapshot

Asymmetric Binding to NS5A by Daclatasvir (BMS-790052) and Analogs Suggests Two Novel Modes of HCV Inhibition

inferred← citeshttps://doi.org/10.1038/nrgastro.2016.60openalex-snapshot

Direct-acting antiviral agents for hepatitis C: structural and mechanistic insights

inferred← citeshttps://doi.org/10.1038/s41598-024-80082-1openalex-snapshot

Computational design of potent dimeric phenylthiazole NS5A inhibitors for hepatitis C virus

inferred← citeshttps://doi.org/10.1080/07391102.2021.1930162openalex-snapshot

A ‘deep dive’ into the SARS-Cov-2 polymerase assembly: identifying novel allosteric sites and analyzing the hydrogen bond networks and correlated dynamics

inferred← citeshttps://doi.org/10.1080/1062936x.2020.1740889openalex-snapshot

QSAR studies on hepatitis C virus NS5A protein tetracyclic inhibitors in wild type and mutants by CoMFA and CoMSIA

inferred← citeshttps://doi.org/10.1080/17460441.2017.1291628openalex-snapshot

Applications of computer-aided approaches in the development of hepatitis C antiviral agents

inferred← citeshttps://doi.org/10.1097/md.0000000000026312openalex-snapshot

Efficacy and safety of danoprevir plus sofosbuvir in GT 1, 2, 3, or 6 chronic hepatitis C patients with or without cirrhosis in China

inferred← citeshttps://doi.org/10.1099/jgv.0.001000openalex-snapshot

Self-association and conformational variation of NS5A domain 1 of hepatitis C virus

inferred← citeshttps://doi.org/10.1128/aac.01269-19openalex-snapshot

Interplay of Amino Acid Residues at Positions 28 and 31 in NS5A Defines Resistance Pathways in Hepatitis C Virus Genotype 2

inferred← citeshttps://doi.org/10.1128/aac.02639-15openalex-snapshot

Synergistic Activity of Combined NS5A Inhibitors

inferred← citeshttps://doi.org/10.1128/aac.03293-14openalex-snapshot

NS5A Inhibitors Impair NS5A–Phosphatidylinositol 4-Kinase IIIα Complex Formation and Cause a Decrease of Phosphatidylinositol 4-Phosphate and Cholesterol Levels in Hepatitis C Virus-Associated Membranes

inferred← citeshttps://doi.org/10.1155/2016/5743521openalex-snapshot

Highlights of the Fourth Canadian Symposium on Hepatitis C: Moving towards a National Action Plan

inferred← citeshttps://doi.org/10.1186/s13065-022-00842-wopenalex-snapshot

Leveraging structural and 2D-QSAR to investigate the role of functional group substitutions, conserved surface residues and desolvation in triggering the small molecule-induced dimerization of hPD-L1

inferred← citeshttps://doi.org/10.1371/journal.pone.0251934openalex-snapshot

The combination of the NS5A and cyclophilin inhibitors results in an additive anti-HCV inhibition in humanized mice without development of resistance

inferred← citeshttps://doi.org/10.14800/rci.825openalex-snapshot

Baby Steps Toward Modelling The Full human Programmed Death-1 (PD-1) Pathway

inferred← citeshttps://doi.org/10.21248/gups.61849openalex-snapshot

Charakterisierung des Lipidbindungsverhaltens und der Proteinfaltung von HCV NS5A unter Einfluss des NS5A-Inhibitors Daclatasvir

inferred← citeshttps://doi.org/10.2147/dddt.s133944openalex-snapshot

Modeling the human Nav1.5 sodium channel: structural and mechanistic insights of ion permeation and drug blockade

inferred← citeshttps://doi.org/10.3390/genes9070343openalex-snapshot

Epistatic Interactions in NS5A of Hepatitis C Virus Suggest Drug Resistance Mechanisms

inferred← citeshttps://doi.org/10.3390/pr9010071openalex-snapshot

Molecular Dynamics Simulations in Drug Discovery and Pharmaceutical Development

inferred← citeshttps://doi.org/10.3390/v11010030openalex-snapshot

Overview of HCV Life Cycle with a Special Focus on Current and Possible Future Antiviral Targets

inferred← citeshttps://doi.org/10.3390/v6114227openalex-snapshot

Resistance Patterns Associated with HCV NS5A Inhibitors Provide Limited Insight into Drug Binding

inferred← citeshttps://doi.org/10.35170/ss.ed.9786586283082.edopenalex-snapshot

CORONAVÍRUS: SARS-COV-2

inferred← citeshttps://doi.org/10.4172/2376-0419.1000e127openalex-snapshot

Immune Checkpoints Inhibitors: A Single Antiviral and Anticancer Magic Bullet

inferred← citeshttps://doi.org/10.4172/2376-0419.1000e131openalex-snapshot

Modelling Off-target Interactions (I): Cardiotoxicity

Editorial review for independent work. ICSAC — the Institute for Complexity Science and Advanced Computing — runs a structured editorial panel for researchers publishing outside journals, and publishes on CiteStamp rails. Submission is free and goes through ORCID: icsacinstitute.org/submit.